A multicentric, phase III clinical trial to assess the immunogenicity and reactogenicity of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed administered to healthy infants at 6, 10 and 14 weeks of age.

Trial Profile

A multicentric, phase III clinical trial to assess the immunogenicity and reactogenicity of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed administered to healthy infants at 6, 10 and 14 weeks of age.

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs DTaP vaccine (Primary)
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top